Related Experiment Video
Updated: Apr 19, 2026
05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
3.8K
Depressive symptoms associated with dabigatran: a case report.
Gul Eryilmaz1, Asli Enez Darcin2, Esra Saglam3
1Department of Psychiatry, Neuropsychiatry Istanbul Hospital, Istanbul, Turkey.
Summary
Depression is common in atrial fibrillation patients. This case report highlights how dabigatran may worsen depressive symptoms in some individuals, emphasizing potential drug interactions.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Atrial fibrillation (AF) is frequently associated with depression and anxiety, impacting patient quality of life.
- Dabigatran is a direct oral anticoagulant used to manage AF.
- Patients with pre-existing depression may be at increased risk for adverse effects during dabigatran therapy.
Observation:
- A 68-year-old male patient with atrial fibrillation experienced worsening depressive symptoms after initiating dabigatran.
- The patient was on multiple prescription medications, raising concerns about potential drug interactions.
Findings:
- The case suggests a possible link between dabigatran use and the exacerbation of depressive symptoms in this patient.
- Drug-drug interactions involving dabigatran and other prescribed medications may have contributed to the observed outcome.
Implications:
- This case underscores the importance of monitoring mental health in atrial fibrillation patients treated with dabigatran.
- Further investigation into the interaction between dabigatran and psychotropic medications is warranted.
- Clinicians should carefully consider patients' psychiatric history when prescribing dabigatran.
